CASE OF THE MONTH: February 1999 - 54 year old man with severe muscle weakness

Michael D. Hill; Juan M. Bilbao

doi:10.1111/j.1750-3639.1999.tb00607.x

CASE OF THE MONTH: February 1999 - 54 year old man with severe muscle weakness

Michael D. Hill^*
, Juan M. Bilbao

^*Corresponding author for this work

University of Toronto

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

A 54 year old man developed rhabdomyolysis one year after beginning treatment with a combination of lorastatin (an HMGCoA reductase inhibitor) and niacin. Muscle biopsy showed a severe necrotizing myopathy affecting both fibre types. Recovery occurred gradually with cessation of medication. The spectrum of cholesterol lowering agent myopathy may include delayed cases of unusual severity.

Original language	English
Pages (from-to)	607-608
Number of pages	2
Journal	Brain Pathology
Volume	9
Issue number	3
DOIs	https://doi.org/10.1111/j.1750-3639.1999.tb00607.x
State	Published - Jul 1999
Externally published	Yes

Access to Document

10.1111/j.1750-3639.1999.tb00607.x

Cite this

@article{4ebf801450574d77a3355e4d296e31dd,

title = "CASE OF THE MONTH: February 1999 - 54 year old man with severe muscle weakness",

abstract = "A 54 year old man developed rhabdomyolysis one year after beginning treatment with a combination of lorastatin (an HMGCoA reductase inhibitor) and niacin. Muscle biopsy showed a severe necrotizing myopathy affecting both fibre types. Recovery occurred gradually with cessation of medication. The spectrum of cholesterol lowering agent myopathy may include delayed cases of unusual severity.",

author = "Hill, \{Michael D.\} and Bilbao, \{Juan M.\}",

year = "1999",

month = jul,

doi = "10.1111/j.1750-3639.1999.tb00607.x",

language = "Ingl{\'e}s",

volume = "9",

pages = "607--608",

journal = "Brain Pathology",

issn = "1015-6305",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - CASE OF THE MONTH

T2 - February 1999 - 54 year old man with severe muscle weakness

AU - Hill, Michael D.

AU - Bilbao, Juan M.

PY - 1999/7

Y1 - 1999/7

N2 - A 54 year old man developed rhabdomyolysis one year after beginning treatment with a combination of lorastatin (an HMGCoA reductase inhibitor) and niacin. Muscle biopsy showed a severe necrotizing myopathy affecting both fibre types. Recovery occurred gradually with cessation of medication. The spectrum of cholesterol lowering agent myopathy may include delayed cases of unusual severity.

AB - A 54 year old man developed rhabdomyolysis one year after beginning treatment with a combination of lorastatin (an HMGCoA reductase inhibitor) and niacin. Muscle biopsy showed a severe necrotizing myopathy affecting both fibre types. Recovery occurred gradually with cessation of medication. The spectrum of cholesterol lowering agent myopathy may include delayed cases of unusual severity.

UR - https://www.scopus.com/pages/publications/0033051851

U2 - 10.1111/j.1750-3639.1999.tb00607.x

DO - 10.1111/j.1750-3639.1999.tb00607.x

M3 - Artículo

C2 - 10416996

AN - SCOPUS:0033051851

SN - 1015-6305

VL - 9

SP - 607

EP - 608

JO - Brain Pathology

JF - Brain Pathology

IS - 3

ER -

CASE OF THE MONTH: February 1999 - 54 year old man with severe muscle weakness

Abstract

Access to Document

Other files and links

Fingerprint

Cite this